Abstract:OBJECTIVES:To investigate the incidence of intra- and extrauterine growth retardation (EUGR) and growth restriction in premature infants, and to illustrate the growth pattern of them in postnatal and infantile period. METHODS:All premature infants were admitted to our neonatal intensive care unit (NICU) during the recent 7 years. The criteria for enrollment were (1) gestational age < 37 weeks; (2) single fetus; (3) admitted within the first 24 hours of life; (4) hospitalization period ≥ 14 days; (5) clinical follow-up persisted till ≥ 3 months of corrected gestational age. Intrauterine growth restriction (IUGR), EUGR and growth restriction were defined as having a measured growth value (weight) that was ≤ 10(th) percentile of Chinese infants' growth curve in corrected age on admission, discharge and follow-up period. Results were analyzed by using SPSS 12.0 statistical software package by chi-square test, rank-sum test, and t test. RESULTS:Two hundred and thirty nine infants were involved, 134 were boys and 105 girls. The incidence of IUGR and EUGR assessed by weight was 25.5% and 40.6%, respectively. The lower the birth weight was, the higher the incidence of IUGR and EUGR was. The percentile of body weight in the growth curve at discharge was lower than that at birth (Z = -7.784, P = 0.000). The incidence of growth restriction assessed by weight was 20.5%, 15.0%, 8.8%, 17.0%, 10.4%, 10.1%, 11.9%, 7.0% at corrected gestational age of 38 - 40 weeks, corrected age of 28 d, 61 d, 91 d, 122 d, 152 d, 183 d, and 274 d, respectively. The incidences of growth restriction were stable when the corrected age was older than 91 days. The incidence of growth restriction in female premature infants at 183 days' corrected age was higher than that in male children (χ(2) = 6.181, P = 0.017), the incidence was 19.3% and 3.8% respectively. During the follow-up period, most of the average body weight of premature infants whose gestational age was < 32 weeks or birth weight ≤ 1500 g were lower than the 50(th) percentile of the growth curve except the average body weight of boys whose gestational age < 32 weeks at corrected age of 2 and 4 months. CONCLUSIONS:Premature and/or low birth weight infants are at high risk of growth restriction, especially very low birth weight infants. The incidence of growth restriction decreased with growth. Long-term prognosis requires further investigation.

A case-control study on influential factors for fetal growth retardation

A case -control study on the risk factors of congenital heart disease among perinatal infants

Placental weight and size in relation to fetal growth restriction: a case-control study

Analysis of affect factors of low birth weight

COMPARISON OF INFLUENCE FACTORS BETWEEN SYMMETRIC AND ASYMMETRIC FETAL GROWTH RETARDATION

Clinical analysis of 198 cases of fetal anomalies and preventive measures

The Association Study Between Multi-nutrient Intervention and Fetal Intrauterine Growth Retardation

Clinical Comparative Analysis of Fetal Growth Restriction With/without Maternal Complications

Clinical Characteristics and Pregnancy Outcomes of Preeclampsia Complicated with Fetal Growth Restriction

The study on large for date infant and its interrelated factors

Case-control study on risk factors of maternal adverse pregnancy outcomes

The investigation of incidence and influence factors of fetal macrosomia in a hospital in Qingdao from 2005 to 2011

Epidemiologic study on iufluencing factors of congenital malformation

Analysis on follow-up results of physical development of infants aged 0～3 years with fetal growth restriction

A case control study on risk factors of fetal macrosomia without gestational diabetes

Effect of Prenatal Nutritional Intervention on Foetal Growth Restriction: a Real-World Study in Shenzhen, China.

Analysis of risk factors of fetal growth restriction in pregnancy with preeclampsia

Incidence of Fetal Macrosomia and Influencing Factors in China from 2006 to 2008

The study on interrelated factor of low birth weight infant

[A Study on the Relationship Between Insulin-Like Growth Factor, Insulin-Like Growth Factor-Binding Protein-3 and Fetal Growth Retardation].

[Dynamic evaluation on body weight gain in premature infants and its significance].